Guiding Principles

Health care is a human right. Those in health care, especially those who stand to gain from the ill health of others, have a moral responsibility to examine what they do, its long-term consequences and to ensure that all may benefit. The support of this should be shared by government, citizens, and non-profit and for-profit organizations. This is not only equitable, but is the best means to balance the influence of any specific constituency and a practical necessity. Any amount remaining from our annual budget at year end remains with ACE and is used to support the following year’s core programs to continue helping Canadians with arthritis.

For its past 20 years, ACE has consistently honored a commitment to its members and subscribers, academic and healthcare professional colleagues, collaborators, government and the public that its work is free from the influence of its funders.

To inform ACE employees and our stakeholders, members, subscribers that we will operate our organization with integrity and abide by the highest standards of lawful and ethical behaviour, ACE has adopted this strict set of guiding principles:
  • ACE requests grants from private and public organizations to support its core program and plans and allocates those funds free from influence;
  • ACE discloses all funding sources in all its activities;
  • ACE does not promote any "brand", product or program on any of its materials or its web site, or during any of its educational programs or activities.
  • ACE employees do not receive equity interest or personal "in-kind" support of any kind from any health-related organization;
  • ACE identifies the source of all materials or documents used;
  • ACE develops positions on health policy, products or services in collaboration with people living with arthritis, academic research community, health care providers and governments free from concern or constraint of its funders or other organizations;
  • ACE employees do not engage in personal activities with its funders;
  • Cheryl Koehn does not own stock or any financial interest in any of its private or public funders.


Over the past 12 months, ACE received grants-in-aid from: Amgen Canada, Arthritis Research Canada, Biogen Canada, Canadian Biosimilars Forum, Canadian Rheumatology Association, Celltrion Healthcare Canada, JAMP Pharma, Novartis Canada, Organon Canada, Pfizer Canada, Sandoz Canada, UCB Canada and the University of British Columbia.

ACE also received unsolicited donations from its community members (people with arthritis) across Canada.

ACE thanks funders for their support to help the nearly 6 million Canadians living with osteoarthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and the many other forms of the disease.